Drugs / Ad5Ag85A
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02337270 | Sep 2017 → Sep 2021 | tuberculosis | McMaster University | Completed | No outcome recorded |
| Phase 1 | NCT00800670 | Jun 2009 → Dec 2012 | tuberculosis | McMaster University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad5Ag85A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00800670 ↗ |
| Modality | Vaccine | “new experimental adenovirus-based vaccine for tuberculosis (TB), Ad5Ag85A” NCT02337270 ↗ |
| Route | Intramuscular | “given by intramuscular injection in healthy subjects” NCT00800670 ↗ |